Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 14, 2020

SELL
$4.78 - $8.26 $1.53 Million - $2.64 Million
-320,000 Closed
0 $0
Q1 2020

May 18, 2020

SELL
$4.0 - $21.53 $272,000 - $1.46 Million
-68,000 Reduced 17.53%
320,000 $1.27 Million
Q4 2019

May 18, 2020

BUY
$13.94 - $24.12 $1.8 Million - $3.11 Million
129,000 Added 49.81%
388,000 $8.32 Million
Q3 2019

Nov 14, 2019

BUY
$13.89 - $23.16 $1.69 Million - $2.83 Million
122,000 Added 89.05%
259,000 $3.93 Million
Q1 2019

May 14, 2019

BUY
$12.61 - $22.33 $718,770 - $1.27 Million
57,000 Added 71.25%
137,000 $2.84 Million
Q4 2018

Feb 14, 2019

BUY
$12.41 - $22.98 $992,800 - $1.84 Million
80,000 New
80,000 $854,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.